Klinar has been conducted its oncology  studies in the below indications:

  • Breast Cancer
  • Small Cell Lung Cancer
  • Non-Small Cell Lung Cancer
  • Rectal Cancer
  • Prostate Cancer
  • Solid Tumors
  • Renal Cell Carcinoma
  • Gastroenteropancreatic Neuroendocrin Tumors
  • Leukemia
  • Graft Versus Host Disease
  • Brain Cancer
  • Gastrointestinal Stromal Tumors
  • Colorectal Cancer
  • Hepatocellular Carcinoma
  • Ovarian Cancer
  • Pancreatic Cancer
  • Melanoma
  • Metastatic Breast Cancer
  • Gastric Cancer
  • Lymphoma
  • Myelodysplastic Syndrome
  • Hepatoblastoma
  • Adjuvant Therapy for Melanoma
  • Fianlimab (ANTI-LAG-3) and Cemiplimab
  • Metastatic Urothelial Cancer
  • Biliary Tract Cancers
  • Hepatocellular Carcinoma
  • Node-positive breast cancer
  • HER2 Metastatik Meme Kanseri

The Best Outsourcing Solution!

Full service CRO with Customer-Oriented project management and proposals

Excellent expertise with more than 350 completed projects.

High level of customer satisfaction with dedicated team work and synergy.

Clear strategies for your projects starting from the beginning.

Project and staff stability.

Quick start-up timelines with good communication to the ECs and RA.

Flexible, proactive, professional teamwork.

Competitive costs, Efficient processes

Open communication to our clients and employees

Good risk mitigation processes and planned business continuinity

Quality Certificates such as MoH GCP Certificate, ISO:27001 Information Security Management.

Micromanagement on project and site performence.

High patient recruitment level and efficient patient retention policies.

Recruitment strategies for targeted populations.